Casdin Capital, LLC - Significant Ownership

Signature - Title
By Eli Casdin /s/ Eli Casdin* - Eli Casdin / Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Casdin Capital, LLC.

Significant Ownership of Casdin Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LAB STANDARD BIOTOOLS INC. Common Stock, par value $0.001 per share 21.6% $89M 80.9M Eli Casdin Feb 28, 2025
BLFS BioLife Solutions, Inc. Common Stock, par value $0.001 per share 12.4% $152M -$19.1M 5.96M -11.2% Casdin Capital, LLC Oct 15, 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 8.7% $14.2M 1.3M Casdin Capital, LLC Dec 31, 2024
TNYA Tenaya Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.3% $3.3M 6.73M Casdin Capital, LLC Mar 4, 2025
IPSC Century Therapeutics, Inc. Common Stock, $0.0001 par value per share 3.7% $1.54M 3.21M Casdin Capital, LLC Mar 31, 2025
CDXS Codexis, Inc. Common Stock, par value $0.0001 per share 0% $0 -$17.6M 0 -100% CASDIN CAPITAL, LLC Sep 30, 2025

Schedules 13D/G Reported by Casdin Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.